Alps Advisors Inc

SEC CIK: 0001376113
Latest filing: Jul 29, 2026

SEC filings (opens in a new tab)

SABS holding history

SAB Biotherapeutics, Inc. in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SABS overview All 13F holders of SABS Full Q2 2026 holdings

Shares (Q2 2026): 77,600
Value: $302.6K
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2021

Holdings of SABS by Alps Advisors Inc, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	77,600	$302.6K	<0.1%	+77,600	New	Holders
Q2 2022	0	$0	0.0%	−45,083−100.0%	Sold out	Holders
Q1 2022	45,083	$170.0K	<0.1%	−5,223−10.4%	Reduced	Holders
Q4 2021	50,306	$393.0K	<0.1%	+50,306	New	Holders